These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 24719266

  • 1. Canine and human sarcomas exhibit predominant FGFR1 expression and impaired viability after inhibition of signaling.
    Schweiger N, Hauck M, Steinhoff H, Sampl S, Reifinger M, Walter I, Kreilmeier T, Marian B, Grusch M, Berger W, Holzmann K, Kleiter M.
    Mol Carcinog; 2015 Sep; 54(9):841-52. PubMed ID: 24719266
    [Abstract] [Full Text] [Related]

  • 2. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
    Ishibe T, Nakayama T, Okamoto T, Aoyama T, Nishijo K, Shibata KR, Shima Y, Nagayama S, Katagiri T, Nakamura Y, Nakamura T, Toguchida J.
    Clin Cancer Res; 2005 Apr 01; 11(7):2702-12. PubMed ID: 15814652
    [Abstract] [Full Text] [Related]

  • 3. Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue Sarcoma.
    Chudasama P, Renner M, Straub M, Mughal SS, Hutter B, Kosaloglu Z, Schweßinger R, Scheffler M, Alldinger I, Schimmack S, Persigehl T, Kobe C, Jäger D, von Kalle C, Schirmacher P, Beckhaus MK, Wolf S, Heining C, Gröschel S, Wolf J, Brors B, Weichert W, Glimm H, Scholl C, Mechtersheimer G, Specht K, Fröhling S.
    Clin Cancer Res; 2017 Feb 15; 23(4):962-973. PubMed ID: 27535980
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.
    Wendt MK, Taylor MA, Schiemann BJ, Sossey-Alaoui K, Schiemann WP.
    Breast Cancer Res; 2014 Mar 11; 16(2):R24. PubMed ID: 24618085
    [Abstract] [Full Text] [Related]

  • 5. Exon III splicing of fibroblast growth factor receptor 1 is modulated by growth factors and cyclin D1.
    Chen G, Wang J, Liu Z, Kornmann M.
    Pancreas; 2008 Aug 11; 37(2):159-64. PubMed ID: 18665077
    [Abstract] [Full Text] [Related]

  • 6. Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.
    Agelopoulos K, Richter GH, Schmidt E, Dirksen U, von Heyking K, Moser B, Klein HU, Kontny U, Dugas M, Poos K, Korsching E, Buch T, Weckesser M, Schulze I, Besoke R, Witten A, Stoll M, Köhler G, Hartmann W, Wardelmann E, Rossig C, Baumhoer D, Jürgens H, Burdach S, Berdel WE, Müller-Tidow C.
    Clin Cancer Res; 2015 Nov 01; 21(21):4935-46. PubMed ID: 26179511
    [Abstract] [Full Text] [Related]

  • 7. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase.
    Panek RL, Lu GH, Dahring TK, Batley BL, Connolly C, Hamby JM, Brown KJ.
    J Pharmacol Exp Ther; 1998 Jul 01; 286(1):569-77. PubMed ID: 9655904
    [Abstract] [Full Text] [Related]

  • 8. Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy.
    Ling L, Tan SK, Goh TH, Cheung E, Nurcombe V, van Wijnen AJ, Cool SM.
    Mol Cancer; 2015 Jul 23; 14():136. PubMed ID: 26201468
    [Abstract] [Full Text] [Related]

  • 9. Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.
    Shiang CY, Qi Y, Wang B, Lazar V, Wang J, Fraser Symmans W, Hortobagyi GN, Andre F, Pusztai L.
    Breast Cancer Res Treat; 2010 Oct 23; 123(3):747-55. PubMed ID: 20024612
    [Abstract] [Full Text] [Related]

  • 10. Thyroid hormone activates fibroblast growth factor receptor-1 in bone.
    Stevens DA, Harvey CB, Scott AJ, O'Shea PJ, Barnard JC, Williams AJ, Brady G, Samarut J, Chassande O, Williams GR.
    Mol Endocrinol; 2003 Sep 23; 17(9):1751-66. PubMed ID: 12805413
    [Abstract] [Full Text] [Related]

  • 11. FGFR antagonist induces protective autophagy in FGFR1-amplified breast cancer cell.
    Chen Y, Xie X, Li X, Wang P, Jing Q, Yue J, Liu Y, Cheng Z, Li J, Song H, Li G, Liu R, Wang J.
    Biochem Biophys Res Commun; 2016 May 20; 474(1):1-7. PubMed ID: 26993162
    [Abstract] [Full Text] [Related]

  • 12. Identification of a fibroblast growth factor receptor 1 splice variant that inhibits pancreatic cancer cell growth.
    Liu Z, Neiss N, Zhou S, Henne-Bruns D, Korc M, Bachem M, Kornmann M.
    Cancer Res; 2007 Mar 15; 67(6):2712-9. PubMed ID: 17363592
    [Abstract] [Full Text] [Related]

  • 13. Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity.
    Vlacic G, Hoda MA, Klikovits T, Sinn K, Gschwandtner E, Mohorcic K, Schelch K, Pirker C, Peter-Vörösmarty B, Brankovic J, Dome B, Laszlo V, Cufer T, Rozman A, Klepetko W, Grasl-Kraupp B, Hegedus B, Berger W, Kern I, Grusch M.
    Cells; 2019 Sep 16; 8(9):. PubMed ID: 31527449
    [Abstract] [Full Text] [Related]

  • 14. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
    Hughes SE.
    Cardiovasc Res; 1996 Sep 16; 32(3):557-69. PubMed ID: 8881516
    [Abstract] [Full Text] [Related]

  • 15. Resistance mediated by alternative receptor tyrosine kinases in FGFR1-amplified lung cancer.
    Adachi Y, Watanabe K, Kita K, Kitai H, Kotani H, Sato Y, Inase N, Yano S, Ebi H.
    Carcinogenesis; 2017 Oct 26; 38(11):1063-1072. PubMed ID: 28968756
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate.
    Naimi B, Latil A, Fournier G, Mangin P, Cussenot O, Berthon P.
    Prostate; 2002 Aug 01; 52(3):245-52. PubMed ID: 12111699
    [Abstract] [Full Text] [Related]

  • 17. Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1.
    Ren M, Hong M, Liu G, Wang H, Patel V, Biddinger P, Silva J, Cowell J, Hao Z.
    Oncol Rep; 2013 Jun 01; 29(6):2181-90. PubMed ID: 23563700
    [Abstract] [Full Text] [Related]

  • 18. Interactions of pancreatic cancer and stellate cells are mediated by FGFR1-III isoform expression.
    Tian X, Chen G, Zhou S, Henne-Bruns D, Bachem M, Kornmann M.
    Hepatogastroenterology; 2012 Jun 01; 59(117):1604-8. PubMed ID: 22683979
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression.
    Kim SH, Ryu H, Ock CY, Suh KJ, Lee JY, Kim JW, Lee JO, Kim JW, Kim YJ, Lee KW, Bang SM, Kim JH, Lee JS, Ahn JB, Kim KJ, Rha SY.
    Int J Mol Sci; 2018 Oct 15; 19(10):. PubMed ID: 30326563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.